Alan S. Levin

2.2k total citations
46 papers, 1.7k citations indexed

About

Alan S. Levin is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Alan S. Levin has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 10 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Alan S. Levin's work include Immunodeficiency and Autoimmune Disorders (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Alan S. Levin is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Alan S. Levin collaborates with scholars based in United States, United Kingdom and Belgium. Alan S. Levin's co-authors include H. Hugh Fudenberg, Vera S. Byers, Lynn E. S̄pitler, Joseph Wybran, Daniel P. Stites, Robert C. Blattberg, D P Stites, R. W. Baldwin, David Ozonoff and R. A. Robins and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Alan S. Levin

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan S. Levin United States 24 883 252 229 181 159 46 1.7k
W. Hallowell Churchill United States 22 657 0.7× 381 1.5× 180 0.8× 266 1.5× 50 0.3× 40 2.0k
Jacob Zighelboim United States 20 577 0.7× 245 1.0× 112 0.5× 316 1.7× 44 0.3× 67 1.3k
Stephen Keller United States 22 438 0.5× 833 3.3× 160 0.7× 186 1.0× 133 0.8× 64 2.0k
Brian V. Jegasothy United States 23 1.4k 1.6× 355 1.4× 398 1.7× 443 2.4× 37 0.2× 37 2.9k
Michelle Moore United States 23 647 0.7× 425 1.7× 80 0.3× 333 1.8× 78 0.5× 54 1.8k
J. C. E. Underwood United Kingdom 22 327 0.4× 411 1.6× 338 1.5× 435 2.4× 26 0.2× 64 1.9k
G Stingl Austria 20 2.0k 2.2× 341 1.4× 286 1.2× 255 1.4× 22 0.1× 32 3.2k
G.M.P. Galbraith United States 27 848 1.0× 569 2.3× 155 0.7× 195 1.1× 21 0.1× 98 2.4k
Lucien Israël France 23 283 0.3× 341 1.4× 173 0.8× 697 3.9× 44 0.3× 107 1.5k
Bruce U. Wintroub United States 31 1.5k 1.7× 830 3.3× 430 1.9× 393 2.2× 30 0.2× 57 3.8k

Countries citing papers authored by Alan S. Levin

Since Specialization
Citations

This map shows the geographic impact of Alan S. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan S. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan S. Levin more than expected).

Fields of papers citing papers by Alan S. Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan S. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan S. Levin. The network helps show where Alan S. Levin may publish in the future.

Co-authorship network of co-authors of Alan S. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Alan S. Levin. A scholar is included among the top collaborators of Alan S. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan S. Levin. Alan S. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giles, Erin D., Katherine L. Cook, Danilo Landrock, et al.. (2025). Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk. JCI Insight. 10(8). 1 indexed citations
2.
Byers, Vera S., et al.. (1994). A Phase II Study of Effect of Addition of Trichosanthin to Zidovudine in Patients with HIV Disease and Failing Antiretroviral Agents. AIDS Research and Human Retroviruses. 10(4). 413–420. 73 indexed citations
3.
Garcia, Paul A., Harry V. Vinters, Rachel Williams, et al.. (1993). Neurological reactions in HIV‐infected patients treated with trichosanthin. Neuropathology and Applied Neurobiology. 19(5). 402–405. 15 indexed citations
4.
Byers, Vera S., Alan S. Levin, J. A. Clegg, et al.. (1990). A phase I/II study of trichosanthin treatment of HIV disease. AIDS. 4(12). 1189–1196. 105 indexed citations
5.
Byers, Vera S., Alan S. Levin, David Ozonoff, & R. W. Baldwin. (1988). Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunology Immunotherapy. 27(1). 77–81. 91 indexed citations
6.
Levin, Alan S. & Vera S. Byers. (1987). Environmental illness: a disorder of immune regulation.. PubMed. 2(4). 669–81. 56 indexed citations
7.
Blattberg, Robert C. & Alan S. Levin. (1987). Modelling the Effectiveness and Profitability of Trade Promotions. Marketing Science. 6(2). 124–146. 66 indexed citations
8.
Levin, Alan S., Kip Amazon, & Arkadi M. Rywlin. (1984). A squamous cell carcinoma that developed in an epidermal nevus. American Journal of Dermatopathology. 6(1). 51–56. 16 indexed citations
9.
Levin, Alan S., et al.. (1979). Immunotherapy of osteogenic sarcoma with transfer factor. Cancer Immunology Immunotherapy. 6(4). 6 indexed citations
10.
Lw, Jones, Alan S. Levin, & Fudenberg Hh. (1975). Glomerular antigen complexes associated with transitional cell carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 140(6). 896–898. 6 indexed citations
11.
Byers, Vera S., Alan S. Levin, James O. Johnston, & Adeline J. Hackett. (1975). Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.. PubMed. 35(9). 2520–31. 36 indexed citations
12.
Levin, Alan S., Vera S. Byers, H. Hugh Fudenberg, et al.. (1975). IMMUNOLOGIC PARAMETERS BEFORE AND DURING IMMUNOTHERAPY WITH TUMOR-SPECIFIC TRANSFER FACTOR. 7 indexed citations
13.
14.
Raubitschek, Andrew, Alan S. Levin, Daniel P. Stites, Edward B. Shaw, & H. Hugh Fudenberg. (1973). NORMAL GRANULOCYTE INFUSION THERAPY FOR ASPERGILLOSIS IN CHRONIC GRANULOMATOUS DISEASE. PEDIATRICS. 51(2). 230–233. 42 indexed citations
15.
Levin, Alan S., H. Hugh Fudenberg, Lawrence D. Petz, & Gordon C. Sharp. (1972). IgG levels in cerebrospinal fluid of patients with central nervous system manifestations of systemic lupus erythematosus. Clinical Immunology and Immunopathology. 1(1). 1–5. 22 indexed citations
16.
Fudenberg, H. Hugh, et al.. (1971). Studies on a biclonal gammopathy.. BMJ. 2(5757). 320.2–320. 4 indexed citations
17.
Stites, Daniel P., et al.. (1971). Immunobiology of Human Lymphoid Cell Lines. The Journal of Immunology. 107(5). 1376–1381. 5 indexed citations
18.
Levin, Alan S., et al.. (1970). A Rapid Radioimmunoassay for Measuring Nanogram Levels of Antigens1. Vox Sanguinis. 18(5). 459–466. 6 indexed citations
19.
Killander, D., Alan S. Levin, Masaharu Inoue, & Eva Klein. (1970). Quantification of immunofluorescence on individual erythrocytes coated with varying amounts of antigen.. PubMed. 19(1). 151–6. 22 indexed citations
20.
Alper, Chester A., Alan S. Levin, & Fred S. Rosen. (1966). Beta-1C-Globulin: Metabolism in Glomerulonephritis. Science. 153(3732). 180–182. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026